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Abstract Spatiotemporal control of leukocyte dynamics
within tissues is critical for successful innate and adaptive
immune responses. Homeostatic trafficking and coordinated
infiltration into and within sites of inflammation and infection
rely on signaling in response to extracellular cues that in turn
controls a variety of intracellular protein networks regulating
leukocyte motility, migration, chemotaxis, positioning, and
cell–cell interaction. In contrast to mesenchymal cells, leuko-
cytes migrate in an amoeboid fashion by rapid cycles of actin
polymerization and actomyosin contraction, and their migra-
tion in tissues is generally referred to as low adhesive and
nonproteolytic. The interplay of actin network expansion,
contraction, and adhesion shapes the exact mode of amoeboid
migration, and in this review, we explore how leukocyte
subsets potentially harness the same basic biomechanical
mechanisms in a cell-type-specific manner. Most of our de-
tailed understanding of these processes derives from in vitro
migration studies in three-dimensional gels and confined
spaces that mimic geometrical aspects of physiological tis-
sues. We summarize these in vitro results and then critically
compare them to data from intravital imaging of leukocyte
interstitial migration inmouse tissues.We outline the technical
challenges of obtaining conclusive mechanistic results from
intravital studies, discuss leukocyte migration strategies
in vivo, and present examples of mode switching during
physiological interstitial migration. These findings are also
placed in the context of leukocyte migration defects in prima-
ry immunodeficiencies. This overview of both in vitro and
in vivo studies highlights recent progress in understanding the
molecular and biophysical mechanisms that shape robust leu-
kocyte migration responses in physiologically complex and
heterogeneous environments.
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Introduction
Several billion immune cells together form the immune sys-
tem that plays the dominant role in host defense against
pathogens. Both the innate (rapid, antigen-independent) and
adaptive (slower, antigen-specific) immune responses provid-
ing such protection require a variety of leukocytes with di-
verse effector functions to exhibit coordinated cell migration,
tissue positioning, and intercellular interactions. Aside from
some sessile immune cell types that seed tissues during em-
bryonic development, most leukocytes traffic through the
body by exiting the bone marrow or thymus, circulating
through the blood and lymphatic system, and entering periph-
eral organs for surveillance or exertion of specific effector
functions [1, 2]. Over the last decade, much progress has been
made in understanding the cell biology of leukocyte migra-
tion. Not only have we learned that this process differs mech-
anistically from the movement of mesenchymal cells such as
fibroblasts or endothelial cells, but also that leukocytes are
very flexible and adopt distinct migration modes depending
on their environmental context [3–5]. For example, leukocyte
motility on two-dimensional (2D) surfaces requires adhesive
forces, whereas migration in three-dimensional (3D) environ-
ments is low adhesive and largely depends on cytoskeletal
deformability. Moreover, immune cell movement is
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coordinated differently in artificial 3D porous networks with
small or large channels, indicating that the specific 3D geom-
etry of an environment can influence the mode of leukocyte
migration.
Given the enormous flexibility of leukocytes in adapting
their locomotion to the organization of such defined in vitro
environments, it is obvious to ask about the natural 3D geom-
etries of physiological tissues and how they influence in situ
immune cell motility, potentially favoring one migration mode
over the other. Initial studies in this area involved video rate
imaging of inflamed vascular endothelium that elicits signals in
interacting leukocytes to undergo a multistep adhesion cascade
and 2D migration along the endothelial lining before undergo-
ing trans- or paracellular emigration from the vessel [6, 7].
Outside the vasculature, leukocytes migrate in the tissue inter-
stitium via fast locomotion that is low adhesive, largely inde-
pendent of the molecular composition of the environment,
preserves tissue structure rather than degrading it, and follows
physiological paths of least resistance [3, 8]. Additional intra-
vital imaging studies based on confocal and especially two-
photon microscopy have revealed a broad range of interstitial
leukocyte motility and migration patterns: largely stationary
macrophage and dendritic cell networks, moderate speed den-
dritic cells crawling into lymphatic vessels, and rapidly moving
T cells, to name just a few [9]. While we know that cells of the
interstitium can provide pro-migratory activation factors or
guidance cues, we are only beginning to understand how the
architecture of this tissue compartment impacts leukocyte mo-
tility. Physiological interstitial environments are organ specific,
very heterogeneous, and dynamically changing, and current
efforts are directed toward characterizing tissue composition,
geometries, and structural properties in diverse organs and
relating these features to leukocyte dynamics in those sites.
In this review, we will critically summarize reductionist
studies of leukocyte migration in vitro and then review our
current knowledge of the functional relationship between
tissue structure and leukocyte migration strategies in lym-
phoid and nonlymphoid organs. We outline the technical
challenges for functionally dissecting interstitial leukocyte
migration in vivo and provide recommendations for improved
experimental design to obtain more insightful results. Given
the heterogeneous environment of most tissues and the adapt-
ability of leukocytes, we discuss whether leukocytes optimize
their interstitial movement by switching between migration
modes in vivo and speculate on potential differences between
leukocyte subsets in this regard. Finally, we briefly touch on
lessons learned from primary immunodeficiencies with leu-
kocyte migration phenotypes. While important contributions
to the analysis of interstitial migration have also been derived
from studies with cancer cells [4, 10, 11] or leukocytes in other
model systems such as zebrafish and Drosophila [12–15], we
limit our discussion primarily to findings involving mamma-
lian primary leukocytes.
Basic principles of leukocyte motility and migration
Many environmental signals can influence the activation state
of leukocytes, regulate their cytoskeleton, and induce adhe-
siveness, which together contribute to cell shape and motility
changes. These factors include cytokines, chemokines,
growth factors, lipids, alarmins, purine and pyrimidine nucle-
otides and their triphosphates, formyl peptides, complement
factors, extracellular matrix fragments, adhesive ligands, and
even more unconventional stimuli such as hydrogen peroxide
or electrical fields [16–19]. Leukocytes perceive such signals
and translate them into intracellular signals that lead to mor-
phological changes such as cell flattening, multidirectional
development of protrusive veils and dendrites, or establish-
ment of cell polarity (Fig. 1a).
Establishing front–back polarity
The development of a front–back axis with an actin-rich
leading edge at the cell front and a contractile trailing edge
(also called “uropod”) at the cell rear precedes cell movement
and is best appreciated in the context of directed migration
toward an external soluble gradient of chemoattractant
(chemotaxis). However, most leukocytes can also self-
polarize in homogeneous fields of soluble chemokines, before
they increase motility and migrate in a nondirected fashion
(chemokinesis) (Fig. 1a). Apart from soluble molecular cues,
leukocytes can perceive cell surface-bound chemoattractants
as gradients or as homogeneous fields and undergo migration
along surfaces in a directed (haptotaxis) or nondirected man-
ner (haptokinesis), respectively (Fig. 1a).
Chemoattractants are classical inducers of cell polarity that
act through G-protein-coupled receptors (GPCR) on intracel-
lular signaling pathways that establish biochemical asymme-
try in the cell [16]. Even in the absence of GPCR stimulation,
cell adhesion alone can induce signaling cascades that polarize
leukocytes [21]. Key intracellular biochemical components
involved in establishing functional polarity downstream of
GPCR signaling are phosphoinositide 3-kinases (PI3K) [22,
23], but PI3K-independent pathways can also mediate leuko-
cyte polarity [24]. The polarized morphology of migrating
leukocytes results from an intracellular biochemical asymme-
try of key cytoskeletal regulators including the best studied
members of the Rho family of small GTPases: Rac (1 and 2),
Cdc42, and Rho A. Rac isoforms and Cdc42 localize to the
front of the cell where Rac mediates F-actin polymerization
and Cdc42 coordinates the persistence of the leading edge [23,
25, 26]. In contrast, RhoA localizes to the myosin II-rich cell
rear where it regulates the cortical rigidity and contractile
activity of the migrating leukocyte. Rho family small
GTPases act as molecular switches and cycle between active
(GTP-bound) and inactive (GDP-bound) states, which are
regulated by various guanine nucleotide exchange factors
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(GEFs), GTPase-activating proteins (GAPs), and guanine nu-
cleotide dissociation inhibitors (GDIs) [25].
Three migration modules that define leukocyte migration
modes
Leukocytes migrate in a fashion resembling crawling amoeba
and lower eukaryotes (“amoeboid” motion) due to rapid cell
shape changes that are almost exclusively driven by the acto-
myosin cytoskeleton [5]. The interplay of three migration
modules largely defines the cell shape and migration mode
of each locomoting leukocyte: (1) Actin polymerization (“P”)
is considered essential for leukocyte movement and contrib-
utes to formation of protrusive cell structures such as den-
drites, pseudopods, and leading edges at the front of migrating
leukocytes. (2) Myosin II-dependent contraction (“C”) of the
actin network can support cell movement by retracting the
back of the cell, which is particularly important for adherent
leukocytes. (3) While actin polymerization and actomyosin
contraction are the major intracellular forces to deform the
cell, migrating leukocytes can optionally increase adhesion
(“A”) through activating receptors of the integrin family,
causing them to stop, spread, or confine migration to an
adhesive substrate (Figs. 1b and 2). The Rho family small
GTPases discussed above represent major signal hubs that act
through several effector molecules to regulate these three
migration modules. Other cytoskeletal components (microtu-
bules, intermediate filaments, septin cytoskeleton) have regu-
latory or supportive functions [27–29].
Actin polymerization is the major protrusive force at the
leading edge ofmigrating leukocytes. Actomyosin contraction
also contributes to protrusion formation by generating intra-
cellular hydrostatic pressure gradients that can lead to ruptures
in the actin cortex, expand membrane, and morphologically
manifest in blebs at the cell front. The intracellular balance of
both actin polymerization and contraction shapes the exact
mode of leukocyte migration [5]. For immune cells, this
results in a morphological spectrum ranging from dendritic
cells with pronounced, multibranched protrusions to some
monocyte subtypes with small filopodia and occasional blebs
(Fig. 2). Inmigrating leukocytes, polymerizing actin protrudes
the membrane at the cell front, while actin filaments move
backward into the cell (retrograde actin flow) [30]. To allow
cell movement, the intracellular forces of actin polymerization
and actomyosin contraction need to be transduced to the
surrounding extracellular environment. Integrin adhesion re-
ceptors are transmembrane receptors that can provide surface
anchorage and couple the retrograde forces of the actin cyto-
skeleton to the underlying extracellular substrate [31, 32]. On
2D surfaces, integrin-mediated adhesion is required for effec-
tive leukocyte migration (Fig. 1b). When dendritic cells and
macrophages were depleted of all integrin receptors or could
not induce high-affinity integrins, they floated in the medium
of ligand-coated 2D cell culture dishes [33]. Some leukocyte
subsets only activate high-affinity integrins when sensing
chemokine-bound surfaces (e.g., dendritic cells), soluble at-
tractants (e.g., neutrophils), or fluid shear forces (e.g., naïve T
cells), which leads to stopping, cell spreading, or surface-
confinedmigration.Whereas neutrophils and Tcells can crawl
just by actin network expansion with minimal adhesion to an
underlying substrate [5], strongly adherent macrophages re-
quire myosin II-dependent contractions at the cell rear to
detach from an adhesive substrate and retract the cell body
during migration (Fig. 2).
In contrast to 2D migration, it is now widely accepted that
interstitial leukocyte motility in vivo and in 3D environments
does not depend on integrin receptors [3, 5]. Early studies in
3D in vitro gels and artificially confined spaces suggested a
leukocyte migration mode independent of strong adhesive
coupling to the environment, but this concept was initially
received with skepticism [34–36]. However, a decade later, a
number of in vivo studies have confirmed integrin-
independent leukocyte migration [8, 33, 37]. Dendritic cells
genetically depleted of all integrin heterodimers did not show
altered migration in skin explants and lymph nodes [33].
Consistent with these findings, dendritic cells lacking the
essential integrin activator talin also showed normal move-
ment in vivo [33] and this behavior has been recently reported
for talin-deficient neutrophils migrating in intact mouse skin
[8]. How leukocytes moving in a 3D environment transduce
their intercellular cytoskeletal forces in an integrin-
independent manner has still not been resolved [38].
Ongoing studies are using 3D gels and artificially confined
spaces in which leukocyte migration is also independent of
integrins to gain insight into this question.
Learning from 3D in vitro systems: collagen gels
and confined spaces
While commonly subsumed as “3D migration systems”, 3D
gels and confined spaces are not totally equivalent (Fig. 1b).
Collagen gels are the most widely used 3D gels and the best
mimics of collagen-rich connective tissues. Leukocytes that
are completely embedded in these fibrillar scaffolds move
through a porous network of fine collagenous fibers.
Confined environments are less complex, can be formed by
two planar surfaces, and comprise any space smaller than the
diameter of a leukocyte. In a classical study by Malawista
et al. [39], human neutrophils with an average diameter of
8 μm performed integrin-independent “chimneying” between
two adjacent glass surfaces with a gap size of 5.7 μm, but not
11.4 μm. Recent developments in microfabrication have led to
a multitude of new custom-made devices that allow precise
experimental control of both the geometry and chemistry of
the environment in which leukocyte migration can be
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examined. Most studies of leukocyte dynamics in confined
spaces are now performed in microchannels of varying width
(usually in the range of 2–8 μm) [40–43]. While straight
microchannels impose directional migration, they can be
modified to guide leukocytes through complex maze-like
geometries [44], constriction rings [45], or decision-
requiring bifurcations [44]. In combination with
microfluidics, these microchannels now also allow dissecting
how chemokine gradient sensing, physical constraints, and
fluid flow together influence leukocyte guidance [46–48].
Since the stiffness and texture of the environment are addi-
tional parameters affecting cell migration, researchers have
begun to develop confined environments with elastic walls
[49] and asymmetric features [50], in the form of micropillars
[51] or structured nanopatterns [52]. While almost any struc-
ture, texture, and geometry seems technically feasible, such
reductionist microfabricated devices will be most useful when
wisely chosen to mimic a particular physiological aspect of
leukocyte tissue migration.
Collagen gels
Collagen gels are predominantly made of type I collagen that
polymerizes to form fibrillar networks. Several experimental
protocols are available for investigating leukocyte random
migration, chemotaxis, or cell–cell interactions [53–56].
Unlike material-dense 3D systems (e.g., Matrigel, hydrogel)
[57], collagen gels form a porous 3D network that allows
nonproteolytic migration of leukocytes [58]. The exact matrix
structure and properties depend on the species and source of
the solubilized collagen (mostly from bovine hides or rat tail)
and specific gelling conditions (time, temperature, pH)
[59–62]. While collagen species and concentration are indi-
cated in most protocols, the exact matrix rigidity, evenness,
elasticity, density, pore sizes, and collagen bundling often
remain undefined [63]. Since these external parameters can
heavily influence leukocyte dynamics, experimental out-
comes can vary and better reporting of these values would
aid the field going forward.
When leukocytes are embedded in 3D collagen gels and
completely surrounded by this scaffold, they can migrate in a
nonadhesive mode as shown by randomly migrating T cells
upon blockade of integrin function [36] or by integrin-
depleted dendritic cells, neutrophils, and B cells moving in a
chemotactic gradient [33]. In contrast, when leukocytes are
layered on top of collagen gels (e.g., in a Transwell), they
require integrin-mediated adhesion to invade the matrix. Once
in the collagenous mesh, leukocyte movement is almost ex-
clusively driven by actin polymerization [33, 64]. Unless actin
flow is completely stalled, leukocyte migration is very robust,
meaning that complete interference with the contraction and
adhesion module or partial block of actin polymerization still
allows residual movement [33]. When facing narrow pores in
denser collagen gels, locomoting leukocytes partially depend
on RhoA activation, Rho-associated protein kinase (ROCK),
and myosin II-dependent contraction [33, 65]. Upon chemical
blockade of ROCK or myosin II, the rigid nucleus of dendritic
cells becomes stuck at small pores in gels of 1.5 mg/ml
collagen concentration. While the trailing edge immobilizes,
the leading edge continues protruding and elongates the cell.
Similarly treated neutrophils of smaller size do not show
impaired motility in 1.5 mg/ml collagen gels, but only in gels
of >3mg/ml collagen concentration [33]. Together with recent
data, this strongly suggests that the restricting pore size
Fig. 1 a Environmental signals induce shape changes, motility patterns,
andmigrationmodes. In physiological environments, leukocytes perceive
multiple signals and integrate them into intracellular signaling cascades to
induce shape changes, cell polarization, or cell migration. In a homoge-
neous field of soluble ligands, leukocytes can (1) increase cytoskeletal
activity, leading to morphological shape changes without cell movement
or (2) induce self-polarization as prerequisite for nondirected cell migra-
tion (chemokinesis). (3) Soluble gradients of external ligands can polarize
cells along the gradient and stimulate directed migration (chemotaxis). (4)
Upon perceiving homogeneous surface-bound chemokines, leukocytes
can increase cell adhesion, self-polarize, and confine their migration in a
nondirected manner along the surface (haptokinesis). For inherently
adhesive immune cell types, haptokinesis might not require the presence
of an activating chemokine (not shown). Leukocytes can migrate by two
forms of haptotaxis: (5) along a gradient of extracellular matrix and
cellular adhesion sites and (6) along a gradient of substrate-bound
chemoattractants. b The environmental geometry supports different leu-
kocyte migration strategies. (1) Movement along 2D surfaces requires
actin polymerization to push the leading edge membrane forward and
surface anchorage to the substrate. Myosin II (red ellipses)-based con-
tractions behind the leading edge detach very adhesive cells from the
substrate and are not necessarily required when cells migrate on low
adhesive substrates. (Insert below) Integrin-mediated adhesions not only
confine migration to the surface, but also inhibit the retrograde actin flow
(green), converting actin polymerization into forward protrusion at the
leading edge. (2) In confined environments, the leukocyte body can exert
lateral pushing forces on the substrate, which is not possible on 2D
surfaces. Intracellular pressure gradients increase friction against the
walls and potentially compensate for adhesion-dependent anchorage.
Friction against the walls can be generated by actin polymerization or
increase in hydrostatic pressure by actomyosin contractions. (Insert
below) Model of leading edge actin flow during adhesive migration in
microchannels (adapted from [20]): Two F-actin networks form at the
leading edge and interact with each other. The “free” network (dark
green) polymerizes from the membrane at the cell front. The “adherent”
network (light green) polymerizes perpendicular to the walls and com-
presses the retrograde flow of the “free” network, converting new poly-
merization against the membrane and enabling forward protrusions (see
text for moleculardetails). (3) In 3D porous environments, leukocytes can
potentially exert the same lateral forces as in confined spaces, but require
additional mechanisms to navigate through meshes, which are not neces-
sary when moving in the open space of a microchannel. Depending on the
leukocyte subtype, multiple frontal protrusions require coordinated cell
shape changes for efficient movement. (4, 5) In physiological tissues,
leukocytes navigate in a very heterogeneous environment with confined
spaces, fibrillar 3D meshes, and 2D surfaces in close proximity, most
likely adapting to the tissue geometry by constant switching of migration
modes. Fibrillar (4) and cell-rich (5) tissues differ in their structure,
composition, and texture, potentially favoring distinct migration
strategies

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depends on the cellular diameter and nuclear size and rigidity
[66, 67].
Unlike in 2D where crawling leukocytes form flat adhesive
lamellipodia, immune cells form protrusions in the form of
pseudopodia, blebs, or filopodia that can extend through ma-
trix pores and branch in the 3D space of the collagen gel
(Figs. 1b and 2). The complexity of the collagenous 3D
environment requires tight coordination of the multiple frontal
protrusions for efficient migration. Indeed, dendritic cells
lacking such coordination mechanisms due to depletion of
the Rho family small GTPase Cdc42 [68] or the Cdc42
effector DOCK8 [69] get entangled in 3D collagen gels, but
can migrate with unaltered speed in the open space of
uniformly structured, nonmesh-like confined environments
of the type described below. However, Cdc42-deficient neu-
trophils that do not form such extensive cell protrusions as
dendritic cells were not entangled and migrated with normal
speeds in collagen networks (T. Lämmermann, unpublished
observation), further confirming that the same 3D matrix
structure has different effects on distinct immune cell types
(Fig. 2).
Changing the 3D matrix geometry rather than the cell
type can also reveal distinct modes of leukocyte migration,
as exemplified with human macrophages. In discussions
on classical leukocyte migration, macrophages are often
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suggests closer relationships to fibroblasts and tumor cells
than other leukocytes. Indeed, macrophages in nonporous,
dense 3D gels (Matrigel, very dense collagen gels) develop
adhesion-rich podosomes and adopt a protease-dependent
mesenchymal migration mode. However, once these cells
are embedded in the porous matrix of loose fibrillar collagen,
they switch to a nonproteolytic, contraction-dependent amoe-
boid migration mode reminiscent of classical leukocyte 3D
migration [57]. Some macrophage subtypes are better in
switching between migration modes than others, arguing for
subset-specific requirements for adapting to the external en-
vironment [70].
Confined spaces
Microfabricated channels have precisely controlled geometry
and structural properties superior to complex nonhomoge-
neous collagenmeshes that provide advantages for some types
of analyses. These reductionist channels can be reconstructed
to address specific aspects of leukocyte migration difficult to
assess in 3D collagen gels [49]. Similar to movement in 3D
collagen gels, leukocytes do not require integrin adhesive
forces when migrating in highly confined environments
[39], and leukocytes that are squeezed between two surfaces














































Fig. 2 Leukocyte subtypes cover a broad spectrum of morphological
amoeboid phenotypes. The force-relationship between the three migra-
tion modules—actin polymerization (“P”), contraction (“C”) and cell
adhesion (“A”)—determines the shape of leukocytes and the exact mode
of migration. This overview of selected leukocyte subtypes presents their
presumptive force balances (displayed as force triangle) based on cell
morphologies in suspension (upper row), 2D adhesive surfaces (middle
row), and 3D porous scaffolds (lower row). Tissue macrophages are
illustrated in an adhesive 3D porous network (e.g., fibronectin) (top)
and nonadhesive 3D porous network (below). Assuming slight differ-
ences in the balanced force interplay between leukocyte subsets, pharma-
cological or genetic interference with actin flow, contraction or cell
adhesion might affect leukocyte interstitial migration in a cell-type-spe-
cific manner
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experimental settings such as under-agarose assays, EZ-
Taxiscan devices, or microfabricated channels (2–8 μm in
diameter). Immature dendritic cells crawling in 4-μm-
diameter, fibronectin-coated microchannels require myosin
II-dependent contractions [40, 41]. Myosin IIA-deficient den-
dritic cells migrate with half the median speed (2.5 μm/min)
of control cells (5 μm/min) [49]. Studies with T cells in
microchannels of various sizes demonstrated the existence of
a confinement optimum for leukocyte motility [42]. With
widths that approximated their girth (7–9 μm), T cells migrat-
ed at peak velocities, but their speed was significantly lower in
channels of smaller (4–5 μm) or larger (12–20 μm) dimen-
sions. Fast cell motility at the optimal confinement was largely
independent of the specific channel coating (integrin ligands
fibronectin or ICAM-1, 20–25 μm/min; nonintegrin ligands
such as casein, 15–20 μm/min). Upon inhibition of myosin
IIA, activated T cells dropped their speeds (7–12 μm/min) at
all microchannel sizes, indicating that myosin IIA optimizes
fast T cell crawling in many environments. When migrating in
ligand-coated microchannels of larger width (20 μm,
fibronectin-coated) that do not provide confinement, T cells
can adopt two distinct migration modes depending on their
balance between cortical tension and adhesiveness: normal T
cells have sufficient contractile tension that counteracts and
limits adhesion to channel walls. Consequently, T cells mi-
grate for short distances along one wall before de-adhering
and “walking” over to the opposing wall (“walking”mode). In
contrast, T cells with decreased cortical tension (e.g., upon
interference with myosin IIA function) rarely detach from one
microchannel wall and instead “slide” along with prolonged
adhesive contacts (“sliding” mode) [42, 71].
While these studies revealed an optimizing role for con-
tractile forces during leukocyte migration in confined spaces,
blockade of myosin II typically decreased cell speed by about
half and still allowed residual movement. A very recent study
investigated leading edge dynamics during the chemotactic
migration of neutrophil-like HL60 cells in microfluidic chan-
nels (5 μm×5 μm) that were coated with integrin ligand [20].
By visualizing F-actin dynamics in combination with FRAP
experiments, this work revealed two distinct F-actin networks
at the leading edge: (1) a dense network at the interface
between the cell and channel walls (the “adherent” network)
and (2) a less dense network in the center of the leading edge
(the “free” network) (Fig. 1b). Similar to classical 2D
lamellipodia, the free F-actin network was polymerized
against the cell membrane at the cell front, had faster F-actin
assembly, and required the actin-nucleating complex Arp2/3
for polymerization. The adherent network polymerized per-
pendicular to this leading edge network against the cell-to-
wall interface and did not require the Arp2/3 complex for
polymerization, but rather depended on actin-nucleating
formins. Since the adherent network grows medially from
the channel walls, it compresses the free network
polymerizing from the membrane at the cell front. This pre-
vents the retrogrademovement of the free F-actin network and
converts its actin polymerization into forward protrusions.
When the free actin network was selectively diminished by
chemical blockade of Arp2/3, cells formed blebs at the cell
front and accelerated in the channel. This switch to a faster
mode of migration now entirely depended on the contractility
of the cell and the adherent F-actin network. Upon chemical
inhibition of formins, the leading edge destabilized and cells
halted migration, in agreement with an essential function of
actin polymerization for leukocyte migration [20]. Since we
have mentioned earlier that leukocytes can migrate in an
integrin-independent manner in confined environments, it will
be interesting to perform similar experiments under nonadhe-
sive conditions and investigate cell migration when the adher-
ent network will most likely not form. This is of particular
interest since nonadherent dendritic cells migrating in con-
finement have been suggested to upregulate actin polymeri-
zation as a compensation mechanism [72].
Physiological leukocyte migration
Studies such as those described above have already taught us
much about the plasticity of leukocytes and their capacity to
adopt several migration strategies in defined 3D environments
and switch between these when external geometries change or
leukocytes lack one of the three migration modules (denoted
“P,” “C,” and “A” above). Future developments in
microfabrication and material sciences in combination with
higher resolution live cell microscopy will provide even more
insights into how leukocyte migration is mediated and con-
trolled. Ultimately, however, we need to understand interstitial
movement within physiological tissue environments that are
very heterogeneous and dynamically changing. In situ migrat-
ing leukocytes often have options when facing multiple ex-
tracellular ligands in the forms of 2D surfaces, confined
spaces, and 3D networks in close proximity to one another
(Fig. 1b). For these reasons, direct analysis of leukocyte
migration in vivo, including the organization of the tissue
environment in which such movement takes place, is critical.
Animal organs are complex and differentially composed of
epithelial, connective, muscle, and nervous tissues according
to their function. Primary (thymus, bone marrow) and second-
ary lymphoid organs (lymph nodes, spleen white pulp, tonsils,
Peyer’s patches, follicles of the mucosa-associated lymphoid
tissues, BALT) have evolved tissue organizations that support
blood cell development, instruct homeostatic immune cell
trafficking, and regulate the tightly controlled steps involved
in initiation of adaptive immune responses. All these tissues
and organs have in common that they are densely packed with
leukocytes embedded in a fine-structured, connective tissue-
type reticulum that functionally compartmentalizes leukocyte
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development and immune responses [73]. In contrast to the
cell-rich lymphoid organs, most nonlymphoid organs predom-
inantly consist of collagenous connective tissue interspersed
with cells of different origins. This tissue organization is
functionally optimized to preserve vital functions (e.g., nutri-
ent uptake, gas exchange, information flow, fluid balance,
metabolism, movement, structural support), and leukocyte
trafficking in the interstitium of nonlymphoid tissue is rather
minimal during tissue homoeostasis. However, upon inflam-
mation or infection, these tissues dynamically change in their
cellular content: Immune cell trafficking in nonlymphoid tis-
sues dramatically increases when blood-recruited inflamma-
tory leukocytes invade and scan the tissue [2] or when tissue-
resident dendritic cells start crawling into lymphatic vessels
[74]. Depending on the type of inflammation, the structure of
the extracellular environment might also undergo changes and
form blisters (nonviscous serous fluid), abscesses (pus), ulcers
(necrotic epithelial cells), and depositions of fibrin. In situa-
tions of wound healing, long-term remodeling of the extracel-
lular matrix occurs when granulation tissues develop.
Many studies relying on static observations of tissue sec-
tions and flow cytometric as well as ELISA analysis of cells
and material extracted from dispersed tissues have provided
valuable insights about the cell types and soluble factors that
contribute to immune homeostasis and inflammatory events.
But to truly relate tissue organization to leukocyte migration,
direct dynamic imaging is required and intravital techniques
have markedly improved our understanding of the choreogra-
phy of immune cell motion, interaction, and function by
visualizing living leukocytes in their natural in vivo
environment.
Intravital imaging and its (current) limitations
Intravital microscopy using single-photon (1P-IVM) or two-
photon (2P-IVM) instruments has made important contribu-
tions to live immune cell imaging in vivo [9]. By exciting
fluorescent dyes and proteins with pulses of near-infrared laser
light, 2P-IVM is the preferred choice for deep tissue imaging
(penetration depth ∼200–300μm)with low tissue damage and
has been applied to many organs. Imaging leukocyte dynam-
ics in live anesthetized mice preserves close to physiological
conditions (nutrient, gas, fluid exchange) and allows long-
term imaging over several hours. Deep tissue imaging is
technically challenging since the heterogeneous nature of the
tissue causes light scattering and absorption that attenuate the
exciting and emitted light and degrade optical resolution. This
is why most published 2P-IVM studies have so far imaged
primarily at the gross cellular level and focused the analysis on
movement, positioning, and interactions. Recent novel tools
and techniques are beginning to permit visualization of intra-
cellular events in vivo [75–79] and progress is being made in
terms of intravital imaging of multiple cell types and tissue
structures in deeper regions, at faster imaging rates, and higher
resolution [80]. When tissue movement due to respiration is
problematic (e.g., lung) or very distant tissue regions need to
be examined, immune imaging is sometimes performed in
whole organ explants or tissue slices, respectively [9]. These
ex vivo models require very tight control of temperature and
tissue oxygenation [81], are less physiological due to addi-
tional cell death and tissue destruction during preparation, and
are usually only used for short-term studies.
Unlike in vitro experiments where cell numbers, the com-
position of the medium, and the geometry of the environment
can be well-controlled, each intravital imaging study observes
events more or less within a “tissue black box”: without
control of the diversity and cellular composition in a particular
imaging field of view, without knowledge of the exact oxygen
levels and cocktail of pro- and antimigratory factors in that
specific tissue region, and in the absence of a complete picture
of the exact tissue architecture. To maximize the information
gained from such in vivo studies and to limit subjectivity/
uncertainty in analysis and interpretation, several “best prac-
tices” have been developed over the past several years for
these types of experiments:
(1) Imaging gene-deficient and control cells side-by-side in
the same tissue volume in each experiment reduces the
number of unmeasured parameters that could influence
interpretation of motility data (Fig. 3). This experimental
setup eliminates problematic quantitative comparisons
based on measurements of cells imaged in different
experiments and animals that can be influenced by the
heterogeneous composition of the specific portion of the
tissue imaged, by varying nutrient availability or oxy-
genation as a consequence of harmful imaging condi-
tions, or by observations made in subtly different states
of tissue inflammation. Functional perturbations based
on systemic or local administration of blocking antibod-
ies or chemical inhibitors are of pharmacological interest,
but remain inconclusive regarding cell-specific effects.
These reagents globally interfere with protein function of
all cells in the body or treated tissue, potentially leading
to indirect effects that influence motility of the cells of
interest and preventing cause–effect conclusions about
migration control with respect to the leukocytes them-
selves. Moreover, monitoring the exact local concentra-
tion of blocking reagents at a certain tissue site is often
difficult and results can be inconclusive when effects are
not seen with the applied material.
(2) Multiplex imaging of leukocyte dynamics together with
visualization of other tissue contents and stromal ele-
ments provides direct insight into how tissue geometry
impacts leukocyte migration modes. Tracking migrating
immune cells in situ can retrieve information about their
cell shape, plasticity, speeds, velocity fluctuations,
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directionality, and meandering, but these tracking data
alone are insufficient when considering the issue of cell-
intrinsic behavior. Leukocytes can be guided by tissue
geometry, stopped by interactions with other cells or
tissue elements, or directed by chemokines in the tissue.
As we have learned before from collagen gels and
microchannels, the external environment heavily influ-
ences the mode of migration and provides contact guid-
ance for immune cells. To address leukocyte migration
modes in correlation to tissue architecture, we require as
much structural information as possible. In Figs. 4 and 5,
we suggest an intravital imaging setup in which immune
cell tracking occurs together with simultaneous analysis
of stromal elements and collagenous fiber bundles, de-
tected by second harmonic generation (SHG), to provide
the best available representation of physiological 3D
geometry. While this experimental approach still does
not provide information about all aspects of the tissue
environment, such simultaneous multichannel visualiza-
tion provides a more accurate picture of how channel-
like structures, dense networks, and surfaces in vivo
relate to cell movement than does collecting information
separately on each element by itself.
With these considerations in mind, we summarize here
leukocyte migration in tissue architectures at opposite sides
of the spectrum, namely collagen-rich (fibrillar) versus cell-
rich environments (Fig. 1b), and explore if (a) tissue structures
impose motility modes, (b) certain locomotion strategies op-
timize trafficking paths or positioning, (c) leukocytes adopt
tissue-specific migration strategies, and (d) immune cell sub-
sets acquire different degrees of plasticity in physiological
tissues.
Fibrillar environments
Most nonlymphoid organs have pronounced connective tissue
components. Type I collagen is the major constituent of most
connective tissues and assembles collagen fibrils and bundled
fibers in the form of interstitial meshes. Together with other
extracellular matrix components such as elastic fibers and
basement membranes, collagenous networks act as a cellular
backbone of most organs and tightly integrate blood vessels,
lymphatics, fat cells, nerves, muscle strands, and glands,
shaping a physiological maze of confined spaces, fibrillar
3D meshes, and perhaps even 2D surfaces (Fig. 1b).
Leukocytes appear to navigate in a nonproteolytic, low adhe-
sive manner in such tissue geometries, passively guided by
paths of least resistance or barriers of dense matrix [3]. Within
each tissue, the fibrillar collagen composition is very hetero-
geneous, with regions of densely packed thick collagen bun-
dles often alternately with areas of loose matrix where leuko-
cytes could penetrate through pores, clefts, and gaps of vari-
ous sizes [59].
B




Fig. 3 Nonadhesive neutrophil migration in the dermal interstitium and
mode switching to adherent crawling at wound centers. a Subcutaneously
injected talin-deficient (red) and control neutrophils (green) were imaged
side-by-side in the same tissue volume to eliminate problematic quanti-
tative comparisons based on measurements of cells imaged in different
experiments and animals. This experimental design minimizes the influ-
ence of tissue heterogeneity between experiments and ensures the same
imaging conditions and nutrient availability for both cell types. Collagen
fibers are visualized by second harmonic generation (SHG) signals
(white), cell tracks are indicated in turquoise. Neutrophils perform che-
motaxis toward sites of sterile tissue damage and migrate in a nonadhe-
sive mode through the dermal interstitium. b When neutrophils congre-
gate at sites of local wounding, the developing cell aggregates remodel
the interstitial fiber architecture and form a collagen-free wound center.
At the transition zone between 3D fibrillar interstitium and the cell-rich,
collagen-free wound zone, neutrophils switch to adhesion-dependent
crawling. Unlike control cells (red), talin-deficient neutrophils (green)
accumulate exactly at the transition zone. Scale bars=20 μm
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Neutrophils
Neutrophils that are recruited from blood vessels upon tissue
injury, inflammation, or infection need to flexibly reorient
themselves in the tissue and migrate with high speeds to sites
of tissue insult. Consistent with this notion, talin-deficient
neutrophils that lack high-affinity integrins have similar
speeds and directionality when migrating side-by-side with
wild-type neutrophils to sites of sterile injury in the ear skin
dermis (Fig. 3a) [8]. Instead of following a haptokinetic prin-
ciple, neutrophils performed chemotactic migration to sites of
tissue damage and amplified local cell death signals by secret-
ing the soluble lipid leukotriene B4 to enhance the radius of



























Fig. 4 Optimized analysis of interstitial leukocyte migration in physio-
logical settings. To dissect cell-intrinsic aspects of leukocyte motility
from external guidance, simultaneous imaging of cell dynamics and tissue
structures is recommended. a 2P-IVM was applied to murine ear skin to
visualize the dermis of a transgenic DsRed+/+ CD11c-YFP+/− B6.Albino
mouse. Ubiquitously expressed DsRed illuminates all stromal elements
(red), YFP-signals highlight endogenous dendritic cells/macrophages
(yellow), and SHG signals reflect collagen bundles (white). The mouse
was crossed to a B6.Albino background to avoid cell death of light-
sensitive melanophages, avoiding laser light-induced artifactual effects
in the tissue. Scale bar=40 μm. b The movement of a wild-type dendritic
cell, presumably not activated, is followed over 14 min in relation to
tissue structures. Simultaneous visualization of cells, stroma, and collagen
gives a closer representation of the 3D tissue geometry and reveals
channel-like structures and dense networks and surfaces. Still, several
other tissue determinants that might influence leukocyte behavior are
unknown, e.g., the potential presence of cytokines and chemokines that
can induce cell shape changes and upregulation of cell adhesion. Scale
bar=10 μm. CD11c-YFP mice were a kind gift of Michel Nussenzweig
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in collagen gels [33] and integrin-blocking studies in intact
mouse skin [82], the interstitial geometry of the dermis ap-
pears to provide sufficient 3D guidance structure to allow
adhesion-independent neutrophil migration based only on
forces generated by the actomyosin cytoskeleton. A recent
study challenged this concept by proposing adhesive
perivascular tracks as “preferential” routes for interstitially
migrating innate phagocytes [83]. A fraction of neutrophils
and monocytes moved at higher speeds when close to
pericytes along arterioles and capillaries in the ear skin.
Based on human pericytes upregulating the integrin ligand
ICAM-1 and the chemoattractant MIF upon exposure to in-
flammatory mediators and the outcome of integrin blockade
of interactions between innate leukocytes and pericytes
in vitro, it was concluded that pericytes could instruct
haptokinetic phagocyte migration along vascular highways
[83]. While chemical interference with MIF function in vivo
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Fig. 5 Correlation of neutrophil migration paths and velocities with
connective tissue structure. a 2P-IVM was applied to murine ear skin to
visualize the dermis of a transgenic DsRed+/− Lyz2-GFP+/− B6.Albino
mouse. Ubiquitously expressed DsRed illuminates all stromal elements
(red), GFP-bright cells represent endogenous neutrophils (green), and
SHG signals reflect collagen bundles. Neutrophil motility was recorded
simultaneously with stromal elements over 30 min. Scale bar=50 μm. b
Cell tracking analysis in relation to tissue structures. (Left)Tracks over the
entire imaging session were plotted for all cells in the tissue volume and
related to the vascular network; 15 % of migrating neutrophils crawled
along vessels (yellow tracks), whereas the remaining cells migrated in the
interstitial spaces between vessels (blue tracks). (Middle) Dragontails
indicate the migration paths covered by individual cells in the last
5 min. The colors of the dragontails indicate instantaneous velocities
(red: fast, green: slow). This particular short time frame suggests that
neutrophils have high instantaneous velocities preferentially when mi-
grating close to vessels. (Right) In contrast to the 5-min interval analysis,
plotting the velocity distributions over the entire imaging session of
30 min (purple: fast, dark blue: slow) revealed that most neutrophils
migrated fastest in interstitial spaces with a loose local collagen network.
c Depending on the graphic representation, neutrophils close to vessels
appear to migrate along the vascular surface (middle left) or along a 2D
surface of collagen matrix (middle right), which might actually be a
channel-like confined space (outer right). Scale bar=50 μm. Lyz2-GFP
mice were a kind gift of Thomas Graf
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these experiments were not conclusive. Since they did not
include internal control cells and the blocking agents were
administered throughout the tissue, the possible confounding
effects of tissue heterogeneity on the one hand and secondary
effects involving alteration of the behavior of other cells in the
tissue on the other cannot be ruled out. We have confirmed
that randomly migrating neutrophils that transiently crawl
along vascular structures can reach higher speeds (Fig. 5),
but in imaging fields of view with large cell numbers, only
10–15 % of the cells moved along vessels, while all other
neutrophils migrate in the collagenous interstitial space
(Fig. 5b). Multiplex imaging of neutrophils, vessels, and
tissue collagen revealed that velocities were equally high for
neutrophils migrating in perivascular versus areas of low
collagen density, while only neutrophils in dense collagen
regions were slower (Fig. 5b). Moreover, the interfaces be-
tween vessels and surrounding collagen network seem to form
microchannel-like confined spaces that, once neutrophils enter
them randomly, optimize rapid leukocyte movement without
strict requirement for cell adhesion (Fig. 5c).
In contrast, an unexpected essential role for integrin-
mediated adhesion mechanisms has recently been discovered
when neutrophils congregate at sites of tissue wounding.
These dense cellular clusters rearrange the collagenous net-
work of the dermis by physically excluding fibers from the
core of the cell infiltrate. Integrin-mediated adhesion is re-
quired to promote strong local neutrophil interactions and
localized migration. When talin-deficient or β2 integrin-
deficient neutrophils were co-injected with control cells, they
migrated unimpaired and with high speeds in the fibrillar
interstitium toward the cellular aggregates (Fig. 3a), but accu-
mulated at the transition zone from collagenous network to the
cell-rich, collagen-free wound center (Fig. 3b). These obser-
vations represent important in situ examples where leukocytes
maintain interstitial motility at the transition zone from fibril-
lar to nonfibrillar tissue geometry by switching from one
migration mode (nonadhesive) to another (adhesive).
Deficiency in either of LFA-1 or Mac-1, both members of
the β2 integrin family, had a measurable effect on central
accumulation, suggesting that both were independently in-
volved in cell adhesion and movement within the cell cluster
[8]. Formation of these cellular clusters further depended on
lipids and chemoattractants that were locally secreted by
neutrophils, presumably activating high-affinity integrins
and inducing the switch to an adhesive motility mode.
While various results have been obtained about the roles of
integrins [84, 85], actin polymerization [86], and myosin II
function [86, 87] in neutrophil interstitial migration in vivo,
the nature of the experiments leaves open questions about
whether the manipulations employed acted directly on the
studied leukocytes or indirectly via other tissue cells. On the
other hand, numerous mouse knockout models for regulators
of actin polymerization and actomyosin contraction have
studied neutrophil function [88–96], but rarely addressed in-
terstitial migration by direct in vivo imaging. One of the few
examples that allowed conclusions about cis-effects comes
from studies with neutrophils lacking Vav GEFs, important
activators of Rac, the major Rho family GTPase to mediate
actin polymerization. When Vav1/2/3-triple-deficient neutro-
phils were co-injected with wild-type cells and their move-
ment analyzed in the dermis of mouse footpads and phalan-
ges, they migrated with 35 % reduced median speeds com-
pared to controls [97].
Tcells
With the exception of some tissue-resident T cell lineages,
most T cell subtypes are recruited from the blood to peripheral
sites of inflammation or infection. In the connective tissue of
the skin, the dynamics of γδ T cells, regulatory T cells, and
memory and effector T cells have been visualized with 2P-
IVM in the context of adaptive immune responses [98–106].
Only recently, though, was T cell interstitial motility investi-
gated with simultaneous acquisition of data on tissue compo-
sition and architecture of the inflamed mouse ear skin [107].
In vitro generated CD4+ T cells were injected at the peak of
ear inflammation, initially induced by local injection of
antigenic peptide with complete Freund’s adjuvant (water-in-
mineral oil emulsion). In this experimental model, inflamma-
tion seemed to have changed the connective tissue in two
ways: (1) the collagen network seemed looser than
uninflamed ear skin, and (2) the matrix glycoprotein fibronec-
tin was widely deposited throughout the dermis. Based on
computational image analysis of T cell tracks recorded toge-
ther with collagen second harmonic generation (SHG) signals,
T cells seemed to preferentially migrate along the collagen
scaffold in inflamed ears. This study proposed a haptokinetic
model of motility where T cells interact through integrin
receptors of the αv family with fibronectin along the matrix
scaffold and raised the interesting point that structural and
contextual changes in inflammatory tissues might affect leu-
kocyte motility. However, two major aspects of the experi-
mental designs limit the conclusions that can be drawn from
the data: (1) off-target tissue effects of systemically adminis-
tered blocking agents and (2) absence of internal control cells
in the same imaging field of view to control for tissue hetero-
geneity and varying imaging conditions. A few other studies
have also observed effector T cell migration along collagen
fibers in cell-rich tumor tissues and infected brains, but these
associations were only occasional [108–110]. As we have
outlined before (Figs. 4 and 5), visualization of cell migration
in relation to collagen SHG signals alone provides a very
limited picture of the physiological 3D geometry and leaves
open questions if collagen fibers truly act as adhesive guid-
ance structure or if they align along a path of least
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resistance where T cells preferentially migrate in a cell-rich
inflammatory environment [106].
Dendritic cells
Unlike neutrophils that are recruited to connective tissues from
the blood stream, many dendritic cells (DCs) are already
tissue-resident and currently serve as the best studied model
for interstitial migration. In homeostatic conditions, DCs form
a cellular network that constantly samples the tissue for poten-
tial microbial entry. Immature DCs have adherent and proteo-
lytic properties that they largely lose upon uptake of foreign
material and sensing of danger signals. During this maturation
process, they upregulate antigen-presenting properties, cyto-
skeletal activity, and chemokine receptors, most importantly
the chemokine receptor CCR7, with the latter guiding them via
lymphatic vessels to the draining lymph nodes [74]. There are
several established techniques for following the sequential
steps of DC migration from the body periphery to the lymph
node, in particular for the subtypes of the skin: epidermal
Langerhans cells and dermal DCs. While “crawl-out” assays
of mouse ear skin explants analyze interstitial migration into
lymphatics, contact sensitization of the ear skin using the
chemical FITC monitors physiological movement of these
endogenous dendritic cells into the lymph node. More com-
monly used are DCs differentiated in vitro from mouse bone
marrow hematopoietic stem cells (BM-DCs) [53]. After sub-
cutaneous (s.c.) injection into mouse footpads, BM-DCs mi-
grate to skin-draining lymph nodes where their arrival can be
quantified. In vitro matured BM-DCs were also applied to ear
explants where they migrated within 30–90 min through the
dermal interstitium into lymphatics, a process that can be
followed with fluorescence confocal laser microscopy. These
“crawl-in” assays preserve some aspects of dermal geometry
and have revealed some details about how DCs enter lymphat-
ic vessels [33, 111, 112]. However, they do not account for
physiological flow of tissue fluids or provide insight into the
dynamic behavior of immature dendritic cells. Alternatively,
ear skin dermis can be surgically exposed in anesthetized mice
preserving fluid flow, but causing tissue damage and inflam-
mation [113]. Other than limited experiments observing en-
dogenous Langerhans cell and dermal DC motility in intact
murine skin of anesthetized mice [114–117], very few of these
studies have addressed DC migration in relation to the inter-
stitial architecture (Fig. 3) [118, 119]. Hence, most of our
knowledge on interstitial DC mechanics comes from
nonimaging studies with gene-deficient cells.
In contrast to neutrophils and other leukocytes with scan-
ning behavior and persistent reorientation in the tissue, once
skin DCs undergo activation, they move in a highly directed
manner to the nearest lymphatic vessel. DC crawling into
lymphatics and the lymph node does not require integrin
receptors [33], ruling out an adhesive pre-formed path that
leads into lymphatic vessels. Instead, DCs are guided in an
integrin-independent manner into lymphatics by tissue-
immobilized gradients of the CCR7 ligand CCL21 [112]. As
mirrored morphologically in their extremely pronounced cell
protrusions, migration of matured DCs is largely based on the
forces of actin polymerization [33]. Accordingly, DCs deplet-
ed in genes that regulate actin dynamics or the architecture of
the actin network show impaired physiological migration
patterns. Double deficiency in Rac1 and Rac2, the major
Rho GTPase isoforms controlling polymerization, yield
completely round BM-DCs that cannot migrate to lymph
nodes upon injection [120]. When DCs lack the Wiskott–
Aldrich syndrome protein (WASp) or the formin mammalian
Diaphanous-related-1 (mDia), both important catalysts for
actin nucleation and polymerization, their migration to the
lymph node is impaired [121–124]. DCs also express actin
regulators that are rarely found in other immune cells. As one
example, Eps8 acts downstream of Rac and is essential for
actin capping and formation of dense actin networks in DCs
[125]. As another example, the actin-bundling protein fascin-1
is specifically induced upon DC maturation [126]. In agree-
ment with an important role for regulating actin-rich protru-
sions, DCs depleted of Eps8 or fascin-1 show impaired mi-
gration to lymph nodes [125, 126].
The role of actomyosin contractions during physiological
DC migration has so far been addressed indirectly through
studies of gene-deficient DCs with altered RhoA or myosin II
activation levels that all lead to reduced DC migration to
lymph nodes [40, 127, 128]. Actomyosin contractions might
not be required all along the DC route to the lymph node, but
only at specific sites where cell squeezing is required. In
agreement with this concept, regulation of myosin II activity
is spatially controlled when DCs need to pass narrow pores
upon entering terminal lymphatics. Here, the semaphorin
Sema3A is produced in lymphatics and signals through the
plexin A1–Nrp1 receptor complex on DCs to induce myosin
II-dependent contraction at local sites of DC entry [129]. A
second receptor–ligand pair regulates lymphatic entry by con-
trolling intracellular GTPase activities: DCs express the C-
type lectin receptor CLEC-2 that can bind to the glycoprotein
podoplanin (PDPN) on lymphatic vessels. CLEC-2 engage-
ment by PDPN leads to upregulation of Rac1 activity and
stimulation of actin polymerization, while RhoA activity is
downregulated and myosin II function decreased. This DC
spreading response seems to support entry into lymph vessels,
since CLEC-2 knockout DCs have 30 % impaired lymphatic
transmigration [130].
In agreement with an essential role for coordinating the
cytoskeleton during physiological interstitial movement, DC
migration is heavily perturbed when cells cannot maintain
their spatial and temporal asymmetries. An important molec-
ular regulatory axis for interstitial motility is DOCK8→
Cdc42→WASp. Cdc42-deficient BM-DCs, generated from
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mice where Cdc42 depletion was restricted to the hematopoi-
etic cell lineage, largely maintained normal cell motility on 2D
surfaces and in confined spaces in vitro. However, these
knockout cells were markedly impaired in their migration
through porous 3D meshes, including movement through the
dermal interstitial space toward lymphatics [68, 131]. A sim-
ilarly profound, but slightly milder, DC phenotype has been
observed in mice deficient in DOCK8, a member of the
DOCK (Dedicator of cytokinesis) family of proteins that
function as GEFs for RhoGTPases. While motility on 2D
surfaces was not significantly affected, DOCK8 knockout
cells failed to migrate in 3D interstitial spaces and their arrival
in lymph nodes was reduced to less than 25 % that of control
cells. Although DOCK8 deficiency did not affect global
Cdc42 activation, DOCK8 acted as Cdc42-specific GEF and
specifically activated Cdc42 activity at the leading edge [69].
Recent descriptions of loss-of-function mutations in the hu-
man gene DOCK8 have revealed a new autosomal recessive
primary immune deficiency and sparked interest into DOCK8
functions [132, 133]. Patients with DOCK8 deficiency present
multiple abnormalities of the immune system, including de-
fective T cell function and elevated IgE levels, leading to
susceptibility to viral, fungal, and bacterial infections [134].
While studies in DOCK8-deficient mouse models revealed
important roles for DOCK8 in long-lasting humoral immunity
[135] and survival of T cell subsets [136–138], it is currently
unknown if defects in interstitial motility contribute to the
phenotypes observed in humans and mice.
In some ways similar to DOCK8 deficiency in regard to
predilection for viral infections, elevated IgE and cutaneous
eczema, Wiskott–Aldrich syndrome (WAS) represents anoth-
er cytoskeletal disorder with various leukocyte migration de-
fects [139, 140]. WAS is a rare X-linked primary immunode-
ficiency characterized by congenital microthrombocytopenia,
moderate-to-severe eczema, recurrent or severe bacterial in-
fections, and an increased incidence of autoimmunity and
malignancies [140]. It is caused by mutations in the WAS
gene that lead to the absence of the Wiskott–Aldrich syn-
drome protein (WASp) or loss of its functional activity.
Classical WAS is related to three other Wiskott–Aldrich syn-
drome protein (WASP) associated diseases caused by reduced
WASp function or expression levels: X-linked thrombocyto-
penia, X-linked neutropenia, and WIP deficiency [141].
Signaling downstream of Cdc42, WASp acts as key effector
for Cdc42 in hematopoietic cells, primarily through activating
the actin-nucleating complex Arp2/3 and promoting actin
polymerization. As seen upon deletion of DOCK8 or Cdc42,
WASp-deficient DCs showed impaired migration to lym-
phatics and lymph nodes in several experimental models
[122–124], implicating an essential regulatory role of the
DOCK8–Cdc42–WASp axis in interstitial DC motility.
From the gene knockout studies summarized here, we have
gained valuable insights into the molecular regulators of actin
network formation, contraction, and cytoskeletal control and
their contribution to interstitial DC migration to lymph nodes.
However, in most of these studies, DC migration was not
prevented and residual motility might have occurred by
switching migration modes. Combining the current gene de-
fect models with imaging of DC movement in relation to
extracellular components will provide a more detailed insight
into how tissue geometry impacts DC motility.
Keeping in mind that nonlymphoid organs primarily
evolved to maintain structural integrity and protect organs,
there is at present little evidence that these interstitial tissue
geometries have been optimized for leukocyte migration.
Cell-rich environments
In contrast to the fibrillar architecture in connective tissues,
other tissues are mainly composed of cellular networks and
lack pronounced matrix structures. Instead of moving within a
stiff collagenous mesh, leukocytes navigate in cell-rich tissues
through a more elastic interstitium in contact with other cell
types. This includes movement through interconnected cell
sheets (e.g., epidermis, intestinal and bronchial epithelia) and
densely packed cells in the form of static networks (e.g.,
central nervous system) or with highly dynamic characteristics
(e.g., secondary lymphoid organs). Trafficking of innate and
adaptive immune cells has been imaged in numerous cell-rich
environments, including epithelial linings [98, 99, 106, 116,
142–144], the parenchyma of the brain [79, 145–149], lym-
phoid organs [1, 9, 150–154], as well as cellular aggregates
such as bacteria-induced granulomas [155–157]. Since most
insights into interstitial leukocyte dynamics in cell-rich envi-
ronments have come from 2P-IVM studies on immune cell
trafficking in lymph nodes, the major anatomical sites for
initiating an adaptive immune response, we specifically focus
on migration strategies of dendritic cells entering the lymph
node and intranodal steady-state trafficking of T cells.
Lymph nodes are encapsulated lymphoid organs with two
entry sites for leukocytes: (a) afferent lymphatics that guide
cells, in particular dendritic cells, from peripheral tissues
through the subcapsular sinus into the functional regions of
the lymph node, and (b) high endothelial venules that enable
blood-circulating leukocytes, in particular lymphocytes, to
directly enter the lymph node. The lymph node parenchyma
is functionally compartmentalized into B cell follicles con-
taining a fibroblastic dendritic cell (FDC) network and a Tcell
zone (paracortex) that is supported by fibroblastic reticular
cells (FRCs). FRCs produce and almost completely cover a
fine 3D network of reticular fibers, forming a stromal scaffold
that serves as the structural backbone of the paracortex [158,
159]. Resident DCs and macrophages align along the FRC
stroma forming a sessile phagocyte network, while T cells
populate the spaces between the strands of this DC–FRC
network [160–163]. Initial 2P-IVM work revealed high
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motility of Tand B cells within lymph nodes and subsequently
concentrated on interactions among T cells, B cells, and DCs,
studies that have greatly shaped our understanding of the
dynamic events at the onset of adaptive immune responses
[9]. Later, it became apparent that T cell tracks were along the
FRC network, suggesting an instructive role of the tissue
stroma [161]. While there are strong indications supporting a
haptokinetic model of lymphocyte trafficking in the lymph
node, we still do not fully understand the underlying
mechanisms.
Tcells
Naïve T cells show highly dynamic migration patterns in the
lymph node paracortex. The movement of T cells sometimes
involves “stop-and-go” behavior, most likely due to collisions
with other cells or environmental obstacles, but perhaps also
due to internal clocks regulating motility persistence under
steady-state conditions [101]. After discovering that T cells
migrated under steady-state conditions in association with the
FRC network, the former concept of “random” lymphocyte
motility changed to “guided randomness” where FRCs act as
scaffold for T cell trafficking. Scanning electron microscopy
images identified numerous T cell microvilli that interacted
with the FRC network, supporting a haptokinetic model of T
cell crawling along FRC surfaces. Several lines of evidence
further strengthened this concept: (1) chemokine signaling
through Gαi with a major contribution of the receptor CCR7
promoted intranodal T cell motility [81, 164–166]; (2) FRCs
express the CCR7 ligands, CCL19 and CCL21, of which the
latter can directly bind to FRCs [167]; (3) FRCs express the
integrin counterligands ICAM-1, ICAM-2, and VCAM-1 [37,
162, 168, 169]; and (4) T cells adhered in an integrin-
dependent fashion to adhesive, chemokine-coated surfaces
under shear flow [37]. Since naïve Tcells express the integrins
LFA-1 and α4β1, CCL21-binding FRCs might serve as ex-
cellent adhesive substrate. It was therefore surprising when
several groups observed prominent T cell motility with only
minimal changes in speed (10–30 % reduction) when integrin
function was perturbed by gene deletions or functional anti-
body blockade [37, 169–171]. Based on these experiments, it
was concluded that LFA-1 is only minimally engaged during
T cell migration in lymph nodes, probably because of missing
shear flow that could activate integrins. However, functional
interference with LFA-1 and ICAM-1 led to slightly lower
velocities and slightly less directed T cell movement, but it
was unclear if this related to T cell crawling along FRCs. In a
recent study, Katakai et al. [162] combined functional
blocking of Tcell adhesion with the visualization of the lymph
node environment and revealed that LFA-1/ICAM-1 interac-
tions promoted a very fast, highly directed T cell migration
mode. Most T cells migrated in close association with the
dense DC network, but where DCs were sparse, T cells were
still able to migrate. In a series of bone marrow chimeric
experiments, ICAM-1 expressed mainly by dendritic cells
was found to promote the high-speed motility mode [162],
in contrast to earlier studies [169]. In conclusion, basal T cell
motility in lymph nodes does not require integrin-mediated
forces, but LFA-1 engagement promotes a 10–40 % faster
motility mode along two superposed ICAM-1- and CCL21-
decorated cellular networks (DCs and FRCs). This might
allow T cells to increase their scanning area and efficiency,
but also to mediate prolonged residency in the lymph node
paracortex, where LFA-1/ICAM-1 interactions have been
shown to counteract early lymph node egress into medullary
sinuses [171].
The basal nonadhesivemigrationmode of Tcells argues for
cytoskeletal forces promoting lymph node interstitial move-
ment, and current work suggests a contributing role of both
actin polymerization and actomyosin contraction. Since myo-
sin II-dependent contractions are often required at sites of
anatomical constriction, it was unclear how important con-
tractile forces were in the cell-dense, nonfibrillar lymph node
environment. Adoptively transferred myosin IIA-deficient
CD8+ T cells showed 26 % lower velocities during intranodal
migration and 49% decrease in their motility coefficient, used
as a measure of the volume a cell can survey over time,
compared to control cells. Due to the loss of contractility,
myosin IIA-deficient T cells showed overadhesive properties
in vitro, which did not lead to significantly increased interac-
tions with FRCs in vivo. In vitro cell–cell attachment assays of
overadhesive myosin IIA-deficient T cells with FRCs, DCs,
lymphatic endothelial cells, or T cells revealed statistically
significant coupling only between T cells. Besides suggesting
that myosin II provides contractile force to limit adhesion to
other cells and optimize migration in a “confined” cell-dense
environment, this work also implicated contact between T
cells as potential interaction surface to generate traction [42].
Upon chemical interference with ROCK function (Y27632)
and contractility, intranodal T cell speeds were minimally
decreased, but motility coefficients reduced to almost the
same extent as myosin IIA knockout Tcells. These differences
between control and Y27632-treated T cells were lost when
interstitial migration was analyzed in lymph nodes of ICAM-
1-deficient mice, arguing that ROCK–myosin II contractile
forces mediate specific detachment from adhesive LFA-1–
ICAM-1 interactions rather than squeezing forces through
anatomically constricted regions [172]. An importance for cell
shape changes during intranodal migration has been shown
for T cells with increased membrane tensions. These were
generated from transgenic mice with constitutive active ezrin,
one of three members of the ezrin–moesin–radixin (ERM)
family of proteins that link cortical actin to the plasma mem-
brane. Transgenic T cells over-expressing this molecule had a
47 % reduction in motility as compared to internal controls in
the structurally complex cortical ridges, while in other lymph
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node areas, the decrease was only 20 %, indicating structural
heterogeneity within the T cell cortex that requires different
degrees of cell shape change for optimal movement [173].
Maintaining a protrusive actin network is essential for T
cell migration, as evidenced from interference with key mol-
ecules controlling F-actin polymerization. Upon genetic de-
pletion of two isoforms of the Rho family GTPase Rac, Rac1
and Rac2, interstitial T cell velocities were severely reduced
by 65 % compared to control cells [174]. T cells deficient in
DOCK2, an important Rac-GEF in T cells, showed also
strongly reduced interstitial motility and intranodal displace-
ment [175]. Dysregulation of the actin cytoskeleton impairs T
cell internodal motility, as seen in T cells that carry a point
mutation in coronin-1A, causing irregular shape and larger
size of leading edges due to increased inhibition of Arp2/3
[176]. Mice mutants for coronin1A showed defective T cell
egress and peripheral T cell deficiencies, which led to the
discovery of coronin1A mutations in a patient with T cell-
deficient, B cell- and NK cell-sufficient severe combined
immunodeficiency (T−B+NK+ SCID) [176].
Dendritic cells
Antigen-laden, activated DCs from peripheral tissues enter the
lymph node through afferent lymphatic vessels ending in the
subcapsular sinus (SCS) [74, 159]. Here, incoming DCs en-
counter a cell-rich lining of subcapsular sinus macrophages,
lymphatic endothelial cells, other DC subsets, and passaging
lymphocytes with a discontinuous basement membrane at the
sinus floor. 2P-IVM studies revealed a prominent elongated
morphology of DCs transmigrating through the SCS into the
interfollicular regions of the lymph node cortex [177]. Cells
elongate when they cannot detach adhesions at the trailing
edge or need to coordinate migration through anatomical
restrictions. The latter seems to apply for DC movement
through the SCS, because adhesion-deficient, integrin-null
BM-DCs transit with similar speeds through SCS and
interfollicular regions [33]. On the other hand, BM-DCs lack-
ing DOCK8 or WASp seemed to migrate poorly through SCS
floors, suggesting that coordination of the actomyosin cyto-
skeleton is required for transit into deeper lymph node regions
[69, 123]. Here, formation of dense actin networks seems
dispensable, because Eps8-deficient BM-DCs were not
retained anywhere in the lymph node [125]. As discussed
above for T cells, DC migration in lymph nodes is also
assumed to follow a haptokinetic model. This view is largely
based on in vitro experiments showing that BM-DCs can
activate integrin-mediated adhesion when sensing surface-
bound chemokine CCL21, leading to preferred migration
along chemokine-coated artificial microfibers [168]. As de-
scribed before, FRC stromal cells express both ICAM-1 and
CCL21, which might support adhesion-dependent
haptokinesis in vivo. Based on immunohistochemical staining
of CCL21 in lymph node sections showing a tissue-bound
gradient in cortical regions, we can even assume a haptotaxis
concept of DC migration in the interfollicular regions [178].
However, alternative scenarios cannot be ruled out in which a
soluble gradient of cleaved CCL21 that was proteolytically
“freed” by DCsmight support directed movement in the tissue
[168]. The findings on integrin-null BM-DCs efficiently tra-
versing interfollicular regions do not rule out the existence of
an adhesion-driven mode of migration [33], but strongly argue
that BM-DCmovement in lymph nodes depends largely on an
integrin-independent strategy of cell deformation. DC migra-
tion into the lymph node parenchyma depends on the receptor
CLEC-2 interacting with its ligand PDPN on FRCs. CLEC-2-
deficient DCs had impaired access to the paracortex and
stayed close to the subcapsular regions, indicating a tissue
instructive role for controlling intracellular GTPase activation,
DC shape changes, and motility [130]. Since almost all of
these studies were based on s.c. injection of BM-DCs, we
currently do not know, however, if the same mechanisms
apply to endogenous and resident DC subsets.
Conclusion
We have summarized here the multiple faces that leukocytes
show during interstitial migration. As we have learned from
in vitro studies, leukocytes are very flexible and can switch
between motility modes. Depending on the environmental
context, their migration can largely depend on cell adhesion
(2D surfaces), actomyosin contraction (confined spaces, dense
fibrillar 3D networks), or actin polymerization alone (loose
fibrillar 3D networks) (Fig. 1b). Moreover, we also know that
these forces can compensate for each other, as evidenced by
HL60 cells that switch their migration within minutes from
protrusive to contractile blebbing mode in microchannels after
losing their free actin network [20]. Based on such experi-
ments in defined 3D geometries, we have come to the notion
that leukocytes can adapt quickly to changing external condi-
tions. There is currently much less known about the exact
migration modes that leukocytes employ to navigate in tis-
sues. The roles of chemokines and other external factors,
acting upstream of cytoskeletal regulation, are understood to
work together and control leukocyte positioning in lymphoid
and nonlymphoid tissues. But only a few intravital dynamic
imaging studies have provided clear insights into how phys-
iological and pathological tissue geometry impacts leukocyte
migration modes. Neutrophils can indeed switch from nonad-
hesive to adhesive migration at a sterile wound transition zone
(Fig. 3) [8], but we do not know if optimal migration by other
leukocyte subtypes also involves switching between adhesive,
nonadhesive–protrusive, and nonadhesive–contractile motili-
ty modes. Several other important questions are still unan-
swered: Are there preferential tissue paths or geometries
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that would favor one migration strategy over the other?
How do pathological changes in the tissue geometry and
composition affect leukocyte migration strategies? If one
interferes with only onemigrationmode, can cells compensate
by switching to another mode? If mode switching occurs, is it
a quick event or does it require gene transcriptional control?
And would such mode switching alter the trafficking path in
the tissue and impact the outcome of an immune response?
For all these questions, we might expect different answers for
each leukocyte subtype (Fig. 2, Table 1). While most of our
current knowledge on interstitial migration stems from some
fewmodel cell types, there is more to explore and variety to be
expected within the realm of endogenous immune cells and
newly discovered subtypes. Our lessons from mouse models
and primary immunodeficiencies already show that mutations
of cytoskeletal regulators affect some immune cell types more
than others. Since cell biologists, material scientists, and im-
munologists will learn from each other, we can soon expect
in vitro devices that mimic physiological interstitium even
better than those available today. This would allow the study
of human leukocytes where intravital microscopy in living
tissue is not an option. It is quite clear that we have not yet
seen all the faces of leukocyte migration.
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